CD4 and neoplasm: Furthermore, 75% of the recognised mutated proteins were identified by CD4 + T cells, while 25% were identified by CD8 + T cells, which indicates the involvement of both CD4 + helper T cells and CD8 + cytotoxic T cells in recognising and targeting tumour-specific mutations.